Search the Appendices of Resolution CM/Res(2018)1
2269 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
TALQUETAMAB | L01FX29 | PT | POM | 22-10-2024 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
GLOFITAMAB | L01FX28 | PT | POM | 22-10-2024 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
MIRVETUXIMAB SORAVTANSINE | L01FX26 | PT | POM | 01-08-2025 | EMEA/H/C/005036 | 14-11-2024 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | PT | POM | 22-10-2024 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
TREMELIMUMAB | L01FX20 | PT | POM | 22-10-2024 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
AMIVANTAMAB | L01FX18 | PT | POM | VALID | ||||
SACITUZUMAB GOVITECAN | L01FX17 | PT | POM | 22-10-2024 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
POLATUZUMAB VEDOTIN | L01FX14 | PT | POM | 05-06-2020 | EMEA/H/C/004870 | 16-01-2020 | VALID | |
ENFORTUMAB VEDOTIN | L01FX13 | PT | POM | 22-10-2024 | EMEA/H/C/005392 | 13-04-2022 | VALID | |
TAFASITAMAB | L01FX12 | PT | POM | 13-10-2021 | EMEA/H/C/005436 | 26-08-2021 | VALID | |
OLARATUMAB | L01FX10 | PT | Not authorised | 27-01-2022 | VALID | |||
MOGAMULIZUMAB | L01FX09 | PT | POM | 05-06-2020 | EMEA/H/C/004232 | 22-11-2018 | VALID | |
ELOTUZUMAB | L01FX08 | PT | POM | 22-08-2017 | EMEA/H/C/003967 | 11-05-2016 | VALID | |
BLINATUMOMAB | L01FX07 | PT | POM | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | PT | POM | EMEA/H/C/003918 | 08-05-2017 | VALID | ||
BRENTUXIMAB VEDOTIN | L01FX05 | PT | POM | VALID | ||||
IPILIMUMAB | L01FX04 | PT | POM | 27-01-2022 | VALID | |||
CATUMAXOMAB | L01FX03 | PT | POM | 01-08-2025 | EMEA/H/C/005697 | 10-02-2025 | VALID | |
GEMTUZUMAB OZOGAMICIN | L01FX02 | PT | POM | 14-11-2018 | EMEA/H/C/004204 | 21-09-2018 | VALID | |
RAMUCIRUMAB | L01FG02 | PT | POM | VALID | ||||
TORIPALIMAB | L01FF13 | PT | POM | 22-10-2024 | EMEA/H/C/006120 | 19-09-2024 | VALID | |
SERPLULIMAB | L01FF12 | PT | POM | 01-08-2025 | EMEA/H/C/006170 | 03-02-2025 | VALID | |
RETIFANLIMAB | L01FF10 | PT | POM | 22-10-2024 | EMEA/H/C/006194 | 19-04-2024 | VALID | |
TISLELIZUMAB | L01FF09 | PT | POM | 22-10-2024 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
DOSTARLIMAB | L01FF07 | PT | POM | 13-10-2021 | EMEA/H/C/005204 | 21-04-2021 | VALID | |
CEMIPLIMAB | L01FF06 | PT | POM | VALID | ||||
ATEZOLIZUMAB | L01FF05 | PT | POM | EMEA/H/C/004143 | 21-09-2017 | VALID | ||
AVELUMAB | L01FF04 | PT | POM | EMEA/H/C/004338 | 18-09-2017 | VALID | ||
DURVALUMAB | L01FF03 | PT | POM | 14-11-2018 | EMEA/H/C/004771 | 20-09-2018 | VALID | |
PEMBROLIZUMAB | L01FF02 | PT | POM | 07-04-2016 | EMEA/H/C/003820 | 17-07-2015 | VALID | |
NIVOLUMAB | L01FF01 | PT | POM | 07-04-2016 | EMEA/H/C/003985 | 19-06-2015 | VALID | |
NECITUMUMAB | L01FE03 | PT | Not authorised | 27-01-2022 | VALID | |||
PANITUMUMAB | L01FE02 | PT | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | PT | POM | 13-10-2021 | EMEA/H/C/005124 | 18-01-2021 | VALID | |
TRASTUZUMAB EMTANSINE | L01FD03 | PT | POM | VALID | ||||
PERTUZUMAB | L01FD02 | PT | POM | VALID | ||||
TRASTUZUMAB | L01FD01 | PT | POM | VALID | ||||
ISATUXIMAB | L01FC02 | PT | POM | 05-10-2020 | EMEA/H/C/004977 | 30-05-2020 | VALID | |
DARATUMUMAB | L01FC01 | PT | POM | 22-08-2017 | EMEA/H/C/004077 | 20-05-2016 | VALID | |
MOXETUMOMAB PASUDOTOX | L01FB02 | PT | Not authorised | 13-10-2021 | VALID | |||
INOTUZUMAB OZOGAMICIN | L01FB01 | PT | POM | 06-11-2017 | EMEA/H/C/004119 | 29-06-2017 | VALID | |
OBINUTUZUMAB | L01FA03 | PT | POM | VALID | ||||
OFATUMUMAB | L01FA02 | PT | POM | 27-01-2022 | VALID | |||
RITUXIMAB | L01FA01 | PT | POM | VALID | ||||
REPOTRECTINIB | L01EX28 | PT | POM | 01-08-2025 | EMEA/H/C/006005 | 13-01-2025 | VALID | |
CAPIVASERTIB | L01EX27 | PT | POM | 22-10-2024 | EMEA/H/C/006017 | 17-06-2024 | VALID | |
PRALSETINIB | L01EX23 | PT | POM | 22-10-2024 | EMEA/H/C/005413 | 18-11-2021 | VALID | |
SELPERCATINIB | L01EX22 | PT | POM | 13-10-2021 | EMEA/H/C/005375 | 11-02-2021 | VALID | |
RIPRETINIB | L01EX19 | PT | POM | VALID | ||||
AVAPRITINIB | L01EX18 | PT | POM | 26-01-2021 | EMEA/H/C/005208 | 24-09-2020 | VALID |